What are the treatment options for Peyronie's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Peyronie's Disease

The treatment of Peyronie's disease should follow a structured approach based on disease phase (active vs. stable), with intralesional collagenase injections being the only FDA-approved non-surgical therapy for stable disease with curvature between 30° and 90°. 1

Disease Classification

  • Active Disease: Characterized by dynamic symptoms, penile pain, developing plaque, and progressive deformity, typically lasting 3-12 months 1
  • Stable Disease: Symptoms unchanged for at least three months, minimal or no pain, established plaque, and stable curvature 1

Treatment Options by Disease Phase

Active Phase Treatment

  1. Pain Management

    • NSAIDs are recommended as first-line therapy for penile pain during the active phase 1
    • Pain should be assessed using a visual analog scale and periodically reassessed 1
  2. Oral Medications

    • NOT RECOMMENDED: Vitamin E, tamoxifen, procarbazine, omega-3 fatty acids, pentoxifylline, or combination therapies have no proven efficacy 1, 2
    • These ineffective treatments may delay more effective interventions 2
    • PDE5 inhibitors (particularly tadalafil 5mg daily) may reduce collagen deposition and show lower curvature progression rates 1
  3. Intralesional Therapies

    • Generally reserved for stable disease 3
    • Collagenase Clostridium histolyticum (CCH) is not indicated for pain management in active disease 3

Stable Phase Treatment

  1. Non-surgical Options

    • Intralesional Collagenase (CCH/Xiaflex): The only FDA-approved non-surgical therapy for stable disease with curvature between 30° and 90° with intact erectile function 1, 3

      • Protocol: Up to eight injections of 10,000 U over 24 weeks with modeling 3
      • Average improvement: 17° versus 9.3° with placebo 3
    • Penile Traction Therapy (PTT): Works through collagen remodeling but requires extended daily use (2-8 hours) 1, 4

    • Low-Intensity Extracorporeal Shockwave Therapy (LI-ESWT): May help with pain relief but not recommended for curvature reduction 1

  2. Surgical Options (for stable disease only, typically after 12-18 months of symptoms)

    • Tunical Plication: Recommended for patients with adequate rigidity for coitus, with curvature improvement rates >90% 1

      • Best for patients with intact erectile function or ED responsive to medications 1
    • Plaque Incision/Excision with Grafting: Option for patients with adequate rigidity, with curvature improvement rates generally >80% 1

      • Most appropriate for patients with intact erectile function or ED responsive to oral medications 1
    • Penile Prosthesis Surgery: Recommended for patients with both ED and penile deformity preventing intercourse despite other therapies 1

      • May require adjunctive procedures like modeling, plication, or incision/grafting for optimal results 1

Treatment Algorithm

  1. Initial Assessment:

    • Determine disease phase (active vs. stable) 1
    • Assess for erectile dysfunction 1
    • Document penile curvature and plaque characteristics 1
  2. For Active Disease:

    • NSAIDs for pain management 1
    • Consider PDE5 inhibitors (tadalafil 5mg daily) 1
    • Avoid ineffective oral therapies 1, 2
  3. For Stable Disease:

    • Without ED:

      • Mild curvature (<30°): Consider observation if not interfering with intercourse 1
      • Moderate curvature (30-90°): Consider intralesional collagenase injections 1, 3
      • Severe curvature (>90°) or failed conservative therapy: Consider surgical options 1
    • With ED:

      • ED responsive to medication: Consider plication or plaque incision/grafting 1
      • ED not responsive to medication: Consider penile prosthesis 1

Common Pitfalls to Avoid

  • Pursuing unproven oral therapies that delay effective treatment 1, 2
  • Failing to distinguish between active and stable disease phases 1
  • Using collagenase specifically for pain relief, which is not its indicated use 3
  • Not considering the impact on erectile function when selecting treatments 1
  • Expecting complete resolution of penile curvature with non-surgical treatments 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pentoxifylline for Peyronie's Disease Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Collagenase Injections for Pain Associated with Penile Curvature in Peyronie's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Peyronie's disease: pharmacological treatments and limitations.

Expert review of clinical pharmacology, 2021

Research

Peyronie's disease: what do we know and how do we treat it?

The Canadian journal of urology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.